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A B ST R AC T 
 
The present study, conducted on three children with cerebral palsy who had voiding dysfunction. 
After collecting demographic information, symptoms of voiding dysfunctions were recorded. Then; 
we did an ultrasonographic evaluation of the bladder to measure residual urine volume. Physiotherapy 
treatment through percutaneous electrical stimulation of the posterior tibial nerve was performed in 
12 sessions. Bladder ultrasonography was repeated after treatment. Abnormal residual urine volume 
became normal in patients with urinary retention. Percutaneous posterior tibial nerve stimulation 
reduces symptoms of voiding dysfunctions in children with cerebral palsy. 
Key Words: Voiding dysfunction; cerebral palsy; percutaneous posterior tibial nerve stimulation.  
                      Copyright © 2017 pediatricurologycasereports.com 
 
Corresponding Author: Farshideh Alishahi,  
Shahid Beheshti University of Medical Sciences, 
Tehran, Iran  
Email: f_alishahi82@ymail.com       
Accepted for publication:  14 October 2016 
 
Introduction 
Neurogenic  bladder   (NGB), a dysfunction of 
urinary bladder and urethra, is caused by 
damaging of neurons  or diseases of the central,  
peripheral or autonomic nervous systems that 
found in many patients with neurologic 
disorders, including cerebral palsy [1], 
multiple sclerosis, Parkinson’s disease, spinal 
cord injury, stroke, spine bifida, caudal equine 
syndrome, diabetes mellitus with autonomic 
neuropathy and unintended squeal following 
pelvic surgery [2]. 
Cerebral palsy (CP) describes a group of 
permanent disorders that occur during motor 
development and posture which refers to a 
non-progressive disorder that occurs in 
developing fetus’ or infant’s brain causing 
limitations in activity. Motor disorders of CP 
are often accompanied by disturbances of 
sensation, perception, cognition, 
communication, and behavior. Epilepsy  and 
musculoskeletal problems are associated with 
secondary disorders [1]. Although upper 
urinary tract damage is not frequent in this 
patient group,  the prevalence of dysfunctional 
voiding symptoms is about 30% [3]. 
Symptoms of urinary tract dysfunction in CP 
are frequently including increased post-void 
residual urine, urge incontinence, urgency, 
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hesitancy and enuresis [1].  Treatment of these 
urinary disorders includes medical therapy, 
physical therapy and surgery [4]. Implantation 
through surgery is an invasive procedure 
sometimes accompanied with pain and 
reoperation. Sacral neuromodulation, 
requiring a permanent implanted stimulator, is 
less suitable for children because implant 
doesn’t grow with the patient [5]. 
Physiotherapy treatments including pelvic 
floor muscle training [6], biofeedback [7], 
posterior tibial nerve stimulation, 
interferential, para sacral, suprapubic, ano-
genital and intra anal electrical stimulation [4]. 
The posterior tibial nerve is a mixed nerve 
containing (L5-S3) fibers, originating from the 
same spinal segments as the parasympathetic 
innervations to the bladder [5]. 
The aim of this study was to investigate the 
efficacy of the noninvasive technique of 
transcutaneous posterior tibial nerve 
stimulation (TPTNS) in CP children with non-
obstructive urinary retention. 
 
Methods 
Children included in this study were seen at the 
Soroosh School in Tehran, Iran between 
October 2013 and July 2014. The procedure 
was approved by local ethic committee (the 
ethic committee number is116/424).   
Three cerebral palsy males with neurogenic 
bladder, aged 13, 15 and 16 –years-old were 
enrolled in a prospective clinical trial of PTNS 
efficacy. Study inclusion criteria were age 
range of 7-16 years, absent lower urinary tract 
infection, the ability to sit on chair, be able to 
say they feel the need to urinate, voiding 
dysfunction symptoms for at least six months, 
no history of physical therapy, medication and 
surgery treatments for voiding dysfunction.  
Ultrasound post void residual urine (PVR)], 
was performed before PTNS [1]. The criteria 
used for an increased in PVR was a volume 
higher than 20 ml [1]. PVR is the amount of 
residual urine in the bladder after a voluntary 
void which is measured by ultrasonography 
device. Ultrasonography is a noninvasive 
convenient and safe  method for evaluating 
lower urinary tract dysfunction (LUTD) in 
children and adults [8]. The PTNS cycle 
consisted of 12 outpatient treatment sessions, 
each lasting 30 minutes. The residual urine 
volume was assessed using ultrasonography  
24 hr after the last TPTNS [1,9]. 
 
Assessment  
Urodynamic study was not available in our 
institution. Trans-abdominal ultrasound (V10 
Accuvix, Medicine, South Korea, and 3.5 
MHZ) and imaging of supine position with the 
legs straight was performed by the 
sonographer during complete relaxation of the 
hip. Abdomen was exposed from xiphoid to 
symphysis pubis. Transducer  was  pressed 
against  the  midline just above the symphysis 
pubis [10]. The bladder urine volume was 
measured by ultrasound before voiding and 
PVR volum was measured immediately after 
voiding [3]. Two ultrasonography were 
performed, one before and one after TPTNS. 
Various reports support the use of the bladder 
scanner in the pediatric setting [8]. 
 
Procedure 
TPTNS was applied unilaterally with two 
adhesive electrodes placed above and behind 
the medial malleolus at the ankle on dominant 
side [9] [Fig. 1]. 
Electrical stimulation (Cefar, Swedish) (FDA's 
official approval) was applied by using charge-
compensated 200 µsec pulses with a pulse rate 
of 20 Hz for 30 min 3 times per week, in 12 
sessions for 1 month [11] [Fig. 2]. The 
intensity level was just above the perception 
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threshold but before that which caused pain 
[9]. Methods, and definitions conform to the 
standards recommended by the International 
Continence Society. 
 
 
Fig. 1. Position of electrodes. 
 
 
Fig. 2. TENS device. 
 
Case 1 
Case one was a 15 year old boy who was 
suffering from Spastic diplegia cerebral palsy, 
had a, urinary retention but mentally was 
normal. His height was measured 157 cm, 
weight 56 kg and BMI 23.3 kg/m2. A 
tranquilizer administrated in sake of 
concentration of the patient. He had kyphosis, 
and able to walk without aid. No medication, 
physical therapy, and surgery had been done 
for his voiding dysfunction. He didn’t have 
urinary tract infection. Bladder trans-
abdominal ultrasonography was done before 
intervention. Residual urine volume was 
abnormal (58 ml). Bladder wall thickness was 
normal according to ultrasonography results 
(3.5 mm). Number of urinate was 4-5 times a 
day before the intervention. TPTNS was 
applied in 12 sessions. Average intensity was 
27 MA. PVR was assessed 24 hr after the last 
TPTNS (PVR=0).  Daily frequent urination 
unchanged (Table 1). No side effects were 
reported. 
 
Table 1. Post void residual before and after 
TPTNS of the patients. 
Cases PVR 
(Before TPTNS) 
PVR 
(After TPTNS) 
1 58 (ml) 0 
2 350 (ml) 2 (ml) 
3 52 (ml) 15.7 (ml) 
 
Case 2 
The second case was a 13 year old boy who 
was suffering from Spastic diplegia cerebral 
palsy, had urinary retention and also was 
mentally educable. His height was measured 
143 cm, weight 40 kg and BMI 19.6 kg/m2. He 
has not been administrated nervous drug. He 
had scoliosis, didn’t walk and dependent on 
wheelchair. No medication, physical therapy, 
and surgery had been for his voiding 
dysfunction. He didn’t have urinary tract 
infection. Bladder trans-abdominal 
ultrasonography was done before intervention. 
Residual urine volume was abnormal (350 ml). 
Bladder wall thickness was normal according 
to ultrasonography results (4 mm). Number of 
urinate was 4 times a day before the 
intervention. Treatment was similar to case 1. 
Average intensity was 16 MA. PVR was 
assessed 24 hr after the last TPTNS and was 
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normal (2 ml). Daily frequent urination 
changed to 5-6 (Table 1). No side effects were 
reported. 
 
Case 3 
The third case was a 16 year old boy who was 
suffering from mixed diplegia cerebral palsy, 
had urinary retention, and was mentally 
educable. His height was measured 160 cm, 
weight 49 kg and BMI 19.6 kg/m2. He has not 
been administered nervous drug. Vertebral 
column was normal, and able to walk by aid. 
No medication, physical therapy, and surgery 
was done for his voiding dysfunction. He 
didn’t have urinary tract infection. Bladder 
trans-abdominal ultrasonography was done 
before intervention. Residual urine volume 
was abnormal (52 ml). Bladder wall thickness 
was normal    according to ultrasonography 
results (4 mm). Number of urinate was 8-10 
times a day before the intervention. Treatment 
was similar to case 1 and 2. Average intensity 
was 17 MA. PVR was assessed 24 hr after the 
last TPTNS and was normal (15/7 ml). Daily 
frequent urination changed to 5-6 (Table 1). 
No side effects were reported. 
 
Discussion 
The concept of neuromodulation or nerve 
stimulation for voiding dysfunction emerged in 
1811 by Bell on the spinal nerve roots. He 
concluded that sensory and motor nerves of the 
anterior roots conduct impulses, while the 
posterior nerve roots responsible for vital 
functions [5].  
  In 1983, McGuire and colleagues first  
reported the posterior tibial nerve electrical 
stimulation [5]. Many other studies reported 
the use of PTNS in neurogenic and non-
neurogenic patients with urgency, frequency, 
urge incontinence and voiding dysfunctions [9, 
11, 12]. To date no studies have been published 
on PTNS in cerebral palsy children with 
LUTD. The results of this study evaluate the 
effect of TPTNS on voiding dysfunction in CP 
and shows the relief of clinical symptoms and 
improve the bladder emptying. The presence of 
a significant amount of residual urine is 
indicative of voiding dysfunction [13]. Our 
data, showing a trend to a decrease in PVR, 
support the case for using TPTNS in CP with 
preserved voluntary voiding. Our results 
confirm the findings of other studies which 
used peripheral stimulation of posterior tibial 
nerve [9,13]. Centrally the PTN projects   to    
the      sacral     spinal cord in the same area 
where the bladder projection is located. The 
sacral micturition center and Onuf’s nucleus 
are most probably areas where the therapeutic 
effect of neuromodulation of the bladder, by 
PTNS, take place [12]. PTNS effects are 
mediated by supra sacral centers of stimulus 
elaboration involving finally cortical 
associative areas [14]. TPTNS seems to 
regulate the activity of the bladder and urethra 
through facilitating voiding reflex, increases 
the contraction of the detrusor and relaxes  
sphincter and pelvic floor muscles [13, 15]. It 
seems that a treatment course of 12 sessions 
each lasting 30 minutes will be effective. The 
continuation of the effect after 12 sessions 
remains unknown and further studies should be 
carried out to evaluate the optimal timing of 
TPTNS administration. 
  
Conclusion 
Chronic TPTNS may be effective to relieve 
intractable clinical symptoms of voiding 
dysfunctions in CP children without side 
effects. The feasibility of TPTNS which can be 
easily used at home, by patient or by their 
carrier, represents a real advantage compare to 
PTNS which requires the insertion of a needle 
close to the Tibial nerve. The optimal modality 
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of chronic stimulation and the maintenance of 
effects in the long term need to be investigated. 
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